BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9862247)

  • 1. Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors.
    Longmore J; Razzaque Z; Shaw D; Davenport AP; Maguire J; Pickard JD; Schofield WN; Hill RG
    Br J Clin Pharmacol; 1998 Dec; 46(6):577-82. PubMed ID: 9862247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan.
    Razzaque Z; Pickard JD; Ma QP; Shaw D; Morrison K; Wang T; Longmore J
    Br J Clin Pharmacol; 2002 Mar; 53(3):266-74. PubMed ID: 11874390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519.
    Longmore J; Boulanger CM; Desta B; Hill RG; Schofield WN; Taylor AA
    Br J Clin Pharmacol; 1996 Oct; 42(4):431-41. PubMed ID: 8904614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
    Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
    Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
    Edvinsson L; Uddman E; Wackenfors A; Davenport A; Longmore J; Malmsjö M
    Clin Sci (Lond); 2005 Sep; 109(3):335-42. PubMed ID: 15853772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.
    van den Broek RW; MaassenVanDenBrink A; Mulder PG; Bogers AJ; Avezaat CJ; John GW; Saxena PR
    Eur J Pharmacol; 2002 May; 443(1-3):125-32. PubMed ID: 12044802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
    van den Broek RW; Bhalla P; VanDenBrink AM; de Vries R; Sharma HS; Saxena PR
    Cephalalgia; 2002 Mar; 22(2):83-93. PubMed ID: 11972574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.
    Razzaque Z; Heald MA; Pickard JD; Maskell L; Beer MS; Hill RG; Longmore J
    Br J Clin Pharmacol; 1999 Jan; 47(1):75-82. PubMed ID: 10073743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: outcome of two independent studies using different experimental protocols.
    Longmore J; Hargreaves RJ; Boulanger CM; Brown MJ; Desta B; Ferro A; Schofield WN; Taylor AA; Hill RG
    Funct Neurol; 1997; 12(1):3-9. PubMed ID: 9127118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cranioselectivity of sumatriptan revisited: pronounced contractions to sumatriptan in small human isolated coronary artery.
    Chan KY; Labruijere S; Ramírez Rosas MB; de Vries R; Garrelds IM; Danser AH; Villalón CM; van den Bogaerdt A; Dirven C; MaassenVanDenBrink A
    CNS Drugs; 2014 Mar; 28(3):273-8. PubMed ID: 24430784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels.
    van den Broek RW; MaassenVanDenBrink A; de Vries R; Bogers AJ; Stegmann AP; Avezaat CJ; Saxena PR
    Eur J Pharmacol; 2000 Oct; 407(1-2):165-73. PubMed ID: 11050304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries.
    Parsons AA; Raval P; Smith S; Tilford N; King FD; Kaumann AJ; Hunter J
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):220-4. PubMed ID: 9700983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine isolated middle cerebral artery contractions to antimigraine drugs.
    Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of binding, functional activity, and contractile responses of the selective 5-HT
    Rubio-Beltrán E; Labastida-Ramírez A; Haanes KA; van den Bogaerdt A; Bogers AJJC; Zanelli E; Meeus L; Danser AHJ; Gralinski MR; Senese PB; Johnson KW; Kovalchin J; Villalón CM; MaassenVanDenBrink A
    Br J Pharmacol; 2019 Dec; 176(24):4681-4695. PubMed ID: 31418454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein.
    Labruijere S; Chan KY; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AJ; Kori SH; MaassenVanDenBrink A
    Cephalalgia; 2015 Feb; 35(2):182-9. PubMed ID: 25078720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B/1D receptor antagonist GR55562.
    Maassen VanDenBrink A; Reekers M; Bax WA; Saxena PR
    Pharmacol Toxicol; 2000 Jun; 86(6):287-90. PubMed ID: 10895993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
    Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R
    Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human basilar artery contractile response to 5-HT and triptans.
    Silva SA; Marques FB; Fontes Ribeiro CA
    Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.